Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to -$344000.0.

  • Tango Therapeutics' Change in Account Payables fell 11128.98% to -$344000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year decrease of 27012.15%. This contributed to the annual value of -$1.2 million for FY2024, which is 3055.72% up from last year.
  • According to the latest figures from Q3 2025, Tango Therapeutics' Change in Account Payables is -$344000.0, which was down 11128.98% from -$880000.0 recorded in Q2 2025.
  • Tango Therapeutics' 5-year Change in Account Payables high stood at $4.5 million for Q3 2022, and its period low was -$2.8 million during Q2 2024.
  • For the 5-year period, Tango Therapeutics' Change in Account Payables averaged around -$8105.3, with its median value being -$344000.0 (2025).
  • The largest annual percentage gain for Tango Therapeutics' Change in Account Payables in the last 5 years was 4353636.36% (2021), contrasted with its biggest fall of 3653756.05% (2021).
  • Quarter analysis of 5 years shows Tango Therapeutics' Change in Account Payables stood at $365000.0 in 2021, then crashed by 384.93% to -$1.0 million in 2022, then surged by 91.54% to -$88000.0 in 2023, then tumbled by 2748.86% to -$2.5 million in 2024, then skyrocketed by 86.28% to -$344000.0 in 2025.
  • Its Change in Account Payables stands at -$344000.0 for Q3 2025, versus -$880000.0 for Q2 2025 and $1.6 million for Q1 2025.